<p>Body weights in Kg (a and b) and in percentage (c and d) are shown for the 100 ng/Kg and 250 ng/Kg dose groups. Monkeys were subjected to an LD<sub>50/30</sub> of TBI at day 0 and subsequently received either vehicle (P5.6TT) or HemaMax subcutaneously at the indicated dosing regimens. Supportive care was prohibited during the study. Body weights were recorded every other day for up to day 30.</p
Two juvenile pigtailed macaques (animals 1 and 2) received total body irradiation (TBI) followed by ...
Objective A Rhesus monkey model was employed to study the radioprotective effects of a Toll-like rec...
YANAGITA, T0M0JI aw Suao TAKAHASHI: Development of tolerance to and physical dependence on barbitura...
<p>Individual dosing groups (a) and the pooled HemaMax dosing group (b) are shown. Animals were subj...
<p>Animals were subjected to an LD<sub>50/30</sub> of TBI at day 0. Animals received subcutaneously ...
<p>(a) Animals received vehicle or m-HemaMax at an ostensible dose of 100 ng/mouse at 24 hours and 7...
<p>Animals received HemaMax subcutaneously at a dose of either 250 ng/Kg or 1000 ng/Kg in the absenc...
<p>Kaplan-Meier plots of non-human primate (NHP) survival over the 40 days following exposure to LD<...
HemaMax, a recombinant human interleukin-12 (IL-12), is under development to address an unmet medica...
HemaMax, a recombinant human interleukin-12 (IL-12), is under development to address an unmet medica...
<p>The plot of plasma AUC<sub>last</sub> of m-HemaMax versus the dose administered to mice in the ab...
<p>Animals received m-HemaMax subcutaneously at a dose of (a) 10 ng/mouse, (b) 20 ng/mouse, (c) 40 n...
<p>Animals received m-HemaMax subcutaneously at a dose of 10 ng/mouse, 20 ng/mouse, 40 ng/mouse, or ...
Purpose: To obtain more accurate information on the dose distribution in rhesus monkeys for total bo...
<p>(a) Temporal kinetics of IFN-γ relative to that of HemaMax. (b) Temporal kinetics of IL-18 and EP...
Two juvenile pigtailed macaques (animals 1 and 2) received total body irradiation (TBI) followed by ...
Objective A Rhesus monkey model was employed to study the radioprotective effects of a Toll-like rec...
YANAGITA, T0M0JI aw Suao TAKAHASHI: Development of tolerance to and physical dependence on barbitura...
<p>Individual dosing groups (a) and the pooled HemaMax dosing group (b) are shown. Animals were subj...
<p>Animals were subjected to an LD<sub>50/30</sub> of TBI at day 0. Animals received subcutaneously ...
<p>(a) Animals received vehicle or m-HemaMax at an ostensible dose of 100 ng/mouse at 24 hours and 7...
<p>Animals received HemaMax subcutaneously at a dose of either 250 ng/Kg or 1000 ng/Kg in the absenc...
<p>Kaplan-Meier plots of non-human primate (NHP) survival over the 40 days following exposure to LD<...
HemaMax, a recombinant human interleukin-12 (IL-12), is under development to address an unmet medica...
HemaMax, a recombinant human interleukin-12 (IL-12), is under development to address an unmet medica...
<p>The plot of plasma AUC<sub>last</sub> of m-HemaMax versus the dose administered to mice in the ab...
<p>Animals received m-HemaMax subcutaneously at a dose of (a) 10 ng/mouse, (b) 20 ng/mouse, (c) 40 n...
<p>Animals received m-HemaMax subcutaneously at a dose of 10 ng/mouse, 20 ng/mouse, 40 ng/mouse, or ...
Purpose: To obtain more accurate information on the dose distribution in rhesus monkeys for total bo...
<p>(a) Temporal kinetics of IFN-γ relative to that of HemaMax. (b) Temporal kinetics of IL-18 and EP...
Two juvenile pigtailed macaques (animals 1 and 2) received total body irradiation (TBI) followed by ...
Objective A Rhesus monkey model was employed to study the radioprotective effects of a Toll-like rec...
YANAGITA, T0M0JI aw Suao TAKAHASHI: Development of tolerance to and physical dependence on barbitura...